Correlation Between Mink Therapeutics and Ardelyx
Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and Ardelyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and Ardelyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mink Therapeutics and Ardelyx, you can compare the effects of market volatilities on Mink Therapeutics and Ardelyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of Ardelyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and Ardelyx.
Diversification Opportunities for Mink Therapeutics and Ardelyx
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Mink and Ardelyx is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and Ardelyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ardelyx and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with Ardelyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ardelyx has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and Ardelyx go up and down completely randomly.
Pair Corralation between Mink Therapeutics and Ardelyx
Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the Ardelyx. But the stock apears to be less risky and, when comparing its historical volatility, Mink Therapeutics is 1.5 times less risky than Ardelyx. The stock trades about -0.06 of its potential returns per unit of risk. The Ardelyx is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 692.00 in Ardelyx on September 1, 2024 and sell it today you would lose (125.00) from holding Ardelyx or give up 18.06% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mink Therapeutics vs. Ardelyx
Performance |
| Timeline |
| Mink Therapeutics |
| Ardelyx |
Mink Therapeutics and Ardelyx Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mink Therapeutics and Ardelyx
The main advantage of trading using opposite Mink Therapeutics and Ardelyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, Ardelyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ardelyx will offset losses from the drop in Ardelyx's long position.| Mink Therapeutics vs. Affimed NV | Mink Therapeutics vs. Adaptimmune Therapeutics Plc | Mink Therapeutics vs. Sangamo Therapeutics | Mink Therapeutics vs. Day One Biopharmaceuticals |
| Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |